Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CNTX US Equity

Context Therapeutics Inc.Health Care · Pharmaceutical Preparations · CIK 1842952 · FY ends Dec 31
$0.49
-0.01 (-1.91%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by MPM BioImpact LLCsec.gov ↗
2026-08-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Blue Owl Capital Holdings LPsec.gov ↗
2026-08-058-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-318-K 3.01Notice of delisting or failure to satisfy a listing rulesec.gov ↗
2026-07-3113G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Octagon Capital Advisors LPsec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-27

Every row is a filed document, checked against its EDGAR index.